Insmed (INSM) shares jumped $32.83 (+33.16%) to $131.85 after it reported a sharply narrower Q2 loss and strong product revenue growth. The company also raised its full-year outlook for Brinsupri, reinforcing the positive earnings trajectory.
Insmed (INSM) shares jumped $32.83 (+33.16%) to $131.85 after it reported a sharply narrower Q2 loss and strong product revenue growth. The company also raised its full-year outlook for Brinsupri, reinforcing the positive earnings trajectory.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment
